Use of Etanercept in Amyloidosis Secondary to Rheumatoid Arthritis: A Report of Two Cases
| Autor: | Antonia María Fernández Rodríguez, Sergio García Pérez, Inmaculada Fernández |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
musculoskeletal diseases medicine.medical_specialty Asymptomatic Receptors Tumor Necrosis Factor Etanercept Arthritis Rheumatoid Colonic Diseases AA amyloidosis medicine Humans Aged business.industry Amyloidosis General Medicine Middle Aged medicine.disease Dermatology Antirheumatic Agents Immunoglobulin G Rheumatoid arthritis Physical therapy Female Kidney Diseases medicine.symptom business medicine.drug |
| Zdroj: | Reumatología Clínica (English Edition). 7:397-400 |
| ISSN: | 2173-5743 |
| DOI: | 10.1016/j.reumae.2011.09.001 |
| Popis: | Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who responded to treatment with etanercept. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect